The pharmaceutical landscape is witnessing a development with the emergence of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 https://robertbore505958.blogolenta.com/37974461/glp-1-patches-a-revolutionary-way-to-control-diabetes